Intelligence · Clinical Development
Pipeline search results
Programs matching “artificial” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 9 pipeline programs matching "artificial" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Anterior lamellar nanostructured artificial human cornea.
Lxo Ireland Designated Activity Company
Severe Trophic Corneal Ulcers Refractory to Conventional Treatment
1 trial -
Bioengineered Artificial Mesenchimal Sheet (BAMS)
Lxo Ireland Designated Activity Company
Venous Ulcer
1 trial -
Hemodialysis with Polymethylmethacrylate Artificial Kidney
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Uremia
1 trial -
Accurate Prediction Artificial Intelligence Models
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Artificial Intelligence Enabled Transvaginal Ultrasound Imaging algorithm
The First People's Hospital of Lianyungang
Ovarian Cancer
1 trial -
Artificial intelligence
Hospital Authority, Hong Kong
Internal Disease
1 trial -
Artificial intelligence in diagnosis
Prime Medicine
Artificial Intelligence (AI) in Diagnosis
1 trial -
Artificial intelligence-assisted chest X-ray in TB screening
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Tuberculosis (TB)
1 trial -
Conventional Artificial Cycle Therapy
Jian Li
Infertility, Female
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.